AzTrials
AzTrials

Preoperative AnxietyNCT07016880

Anxiety, Physiological Parameters, Patient Satisfaction and VR in Gynecological Oncology Surgery

A study testing Virtual Reality Relaxation Session in people with Preoperative Anxiety and Women's Health, run by Hacettepe University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Surgical procedures often cause significant anxiety in patients, particularly among women undergoing gynecological oncology surgeries. Preoperative anxiety is a common and preventable condition that can negatively affect both physiological parameters and the overall surgical experience. Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
Virtual Reality Relaxation Session
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Jul 2025to 15 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The participant must have a confirmed diagnosis of gynecological cancer.
  • The participant must be aware of their gynecological cancer diagnosis.
  • Participants must be 18 years of age or older.
  • Verbal and written informed consent to participate in the study must be obtained.
  • The participant must be able to communicate verbally and in writing in Turkish.
  • No communication impairments (e.g., visual, auditory, or cognitive) should be present.
Show all 9Show fewer
  • This must be the participant's first surgical intervention related to gynecological oncology.
  • Eastern Cooperative Oncology Group (ECOG) Performance Status must not exceed 2.
  • The planned surgical procedure must be a laparotomy.

Who cannot join

  • History of recurrent gynecological cancer.
  • Presence of vision problems that prevent the use of VR goggles, including participants who wear glasses or have uncorrected vision impairment.
  • Presence of conditions such as migraines, vertigo, active nausea, vomiting, or frequent headaches.
  • Sensitivity to motion sickness.
  • Diagnosis of a psychiatric condition, whether under pharmacological or non-pharmacological treatment.
  • Withdrawal of consent during the study.
  • Removal of the virtual reality headset during the intervention.
  • Development of any medical complications during the intervention period.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Fatma Uslu Sahan, Assoc Prof contact

+90 534 224 59 80

fatma.uslu@hacettepe.edu.tr

Turkey (Türkiye)1 site, 1 recruiting
  • Hacettepe University

    Ankara, 06100

    Melike Sahingöz, PhD Student, +90 545 375 64 94, melike.shngz@gmail.com

    Ozhan Ozdemir, Professor, +90 505 225 50 78, ozhan.ozdemir@saglik.gov.tr

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Virtual Reality Intervention on Preoperative Anxiety, Physiological Parameters and Patient Satisfaction in Women Scheduled for Gynecological Oncology Surgery: A Randomised Controlled Trial

Surgical procedures often cause significant anxiety in patients, particularly among women undergoing gynecological oncology surgeries. Preoperative anxiety is a common and preventable condition that can negatively affect both physiological parameters and the overall surgical experience. It may lead to increased heart rate, elevated blood pressure, respiratory distress, and psychological discomfort, increasing the risk of complications during and after surgery. Women facing gynecological cancer surgery often experience heightened anxiety due to concerns about survival, loss of reproductive organs, body image changes, and sexual health.

Virtual reality (VR) has emerged as a promising non-pharmacological approach for reducing preoperative anxiety. By immersing patients in a calming virtual environment that engages visual and auditory senses, VR helps promote relaxation, reduce stress, and enhance the patient's sense of control before surgery. It is safe, easy to implement, cost-effective, and does not have the side effects associated with medications.

Read more

Although VR has demonstrated effectiveness in reducing anxiety in various surgical contexts-including orthopedic, colorectal, and minor gynecological procedures-its impact in gynecologic oncology surgery remains underexplored. This randomized controlled trial aims to evaluate the effect of a VR intervention on preoperative anxiety, physiological parameters (blood pressure, heart rate, respiratory rate, oxygen saturation), and patient satisfaction in women scheduled for gynecologic oncology surgery.

Participants will be randomly assigned to either the intervention group (receiving VR) or the control group (receiving standard care). Anxiety and physiological measures will be evaluated before and after the respective intervention in both groups. Patient satisfaction will be assessed once, immediately after the intervention and before surgery.

The primary objective is to assess whether VR effectively reduces preoperative anxiety and stabilizes physiological indicators. The secondary objective is to evaluate patient satisfaction with the preoperative experience. This study will contribute to the evidence base for using VR as a nursing-led, non-invasive strategy to enhance surgical care in gynecologic oncology.

Read the detailed description

Preoperative anxiety is a common and preventable psychological condition that significantly affects surgical outcomes and patient well-being. Women undergoing gynecologic oncology surgery often face elevated levels of anxiety due to the severity of their diagnosis, potential loss of reproductive organs, and concerns related to survival, body image, and sexuality. These psychological stressors can lead to physiological changes such as increased blood pressure, heart rate, and respiratory distress, which in turn may complicate surgical procedures and recovery. Managing preoperative anxiety effectively is essential not only to minimize surgical risk but also to improve patient satisfaction and postoperative adaptation.

Pharmacological methods used to manage preoperative anxiety can carry risks such as side effects, drug interactions, and delayed postoperative recovery. For this reason, non-pharmacological interventions such as virtual reality (VR) have gained popularity in recent years. VR allows patients to be immersed in a multisensory virtual environment that helps distract their attention away from surgery-related fears and fosters relaxation. Studies in orthopedic, colorectal, and minor gynecologic procedures have shown that VR can reduce anxiety and improve physiological responses before surgery. However, limited evidence exists regarding its use in women undergoing gynecologic oncology surgery-a population that faces unique psychological and physical challenges.

This study is a two-arm randomized controlled trial designed to evaluate the effectiveness of a virtual reality (VR) intervention in reducing preoperative anxiety and stabilizing physiological parameters in women scheduled for gynecologic oncology surgery via laparotomy. A total of 66 participants will be randomly assigned to either the intervention group (VR session) or the control group (standard care). In both groups, anxiety levels and physiological parameters (blood pressure, heart rate, respiratory rate, and oxygen saturation) will be assessed before and after the intervention. Patient satisfaction with preoperative care will be assessed only once, following the intervention or standard care session, immediately before surgery.

Eligibility criteria include adult women (≥18 years) with a confirmed diagnosis of gynecologic cancer who are aware of their diagnosis and scheduled for their first surgical intervention via laparotomy. Participants must have an ECOG Performance Status ≤2 and must not have any cognitive, visual, auditory, or psychiatric impairments that could interfere with communication or VR use. Exclusion criteria include recurrent cancer, motion sensitivity (e.g., vertigo or migraines), or any condition preventing the use of VR headsets.

The study aims to contribute new evidence supporting the use of VR as a nurse-led, low-risk, and effective non-pharmacological approach to improve preoperative experiences and perioperative outcomes in women facing gynecologic oncology surgery.

Being tested
Virtual Reality Relaxation Session
Keywords
Gynecological Surgery, Gynecological Oncology, Preoperative Anxiety, Preoperative Anxiety Management, Virtual Reality

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality Relaxation SessionBehavioural

    A 20 minute virtual reality session using visual and auditory stimuli for relaxation before surgery. Delivered via VR headset.

Study groups in NCT07016880
Study groupRoleWhat they receive
Virtual Reality GroupExperimentalParticipants in this group will receive a virtual reality intervention before surgery. Anxiety, physiological parameters, and satisfaction will be assessed both before and after the VR session.
Receives: Behavioral: Virtual Reality Relaxation Session
Standard Care GroupNo interventionParticipants in this group will receive standard preoperative care. The same measurements will be taken before and after standard care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preoperative Anxiety Score

    Change in anxiety levels as measured by the State-Trait Anxiety Inventory - State subscale (STAI-S), a 20-item scale ranging from 20 to 80. Higher scores indicate greater anxiety.

    Measured: Immediately before and immediately after the intervention, on the day of surgery

  2. Change in Systolic and Diastolic Blood Pressure

    Change in systolic and diastolic blood pressure measured in mmHg, recorded using a calibrated automated monitor.

    Measured: Immediately before and immediately after the intervention, on the day of surgery

  3. Change in Heart Rate

    Change in heart rate measured in beats per minute (bpm), recorded using standard physiological monitoring equipment.

    Measured: Immediately before and immediately after the intervention, on the day of surgery

  4. Change in Respiratory Rate

    Change in respiratory rate recorded in breaths per minute using standard clinical observation.

    Measured: Immediately before and immediately after the intervention, on the day of surgery

  5. Change in Peripheral Oxygen Saturation

    Change in oxygen saturation levels (%) measured using pulse oximetry.

    Measured: Immediately before and immediately after the intervention, on the day of surgery

Secondary outcomes (1)
  1. Preoperative Patient Satisfaction Score

    Patient satisfaction will be assessed using a Visual Analog Scale (VAS), ranging from 0 to 10, where zero indicates 'Not satisfied at all' and 10 indicates 'Extremely satisfied.' Participants will be asked to rate their overall satisfaction with the care they received throughout the preoperative period.

    Measured: Immediately after the intervention (same day, pre-surgery)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2025
  2. Study start15 Jul 2025
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion15 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
66 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07016880
Sponsor's protocol ID
2024/93
Status last verified
Sep 2025
First submitted
21 May 2025
Last updated
10 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Koo CH, Park JW, Ryu JH, Han SH. The Effect of Virtual Reality on Preoperative Anxiety: A Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2020 Sep 29;9(10):3151. doi: 10.3390/jcm9103151.

    PubMed 33003411
  • Vogt L, Klasen M, Rossaint R, Goeretz U, Ebus P, Sopka S. Virtual Reality Tour to Reduce Perioperative Anxiety in an Operating Setting Before Anesthesia: Randomized Clinical Trial. J Med Internet Res. 2021 Sep 1;23(9):e28018. doi: 10.2196/28018.

    PubMed 34252034
  • Asiri S, Guilhermino M, Duff J. The effectiveness of using virtual reality technology for perioperative anxiety among adults undergoing elective surgery: a randomised controlled trial protocol. Trials. 2022 Dec 2;23(1):972. doi: 10.1186/s13063-022-06908-3.

    PubMed 36461040
  • Turrado V, Guzman Y, Jimenez-Lillo J, Villegas E, de Lacy FB, Blanch J, Balibrea JM, Lacy A. Exposure to virtual reality as a tool to reduce peri-operative anxiety in patients undergoing colorectal cancer surgery: a single-center prospective randomized clinical trial. Surg Endosc. 2021 Jul;35(7):4042-4047. doi: 10.1007/s00464-021-08407-z. Epub 2021 Mar 8.

    PubMed 33683433

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Relaxation Session in people with Preoperative Anxiety and Women's Health, run by Hacettepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Fatma Uslu Sahan, Assoc Prof (+90 534 224 59 80, fatma.uslu@hacettepe.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Preoperative Anxiety Score (time frame: Immediately before and immediately after the intervention, on the day of surgery). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07016880, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in